v3.25.4

EARNINGS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2025
Earnings Per Share [Abstract] |
EARNINGS PER SHARE | EARNINGS PER SHARE
| For the year ended December 31,
| (in millions, except per share data)
| 2025 |  | 2024 |  | 2023
Income (loss) from continuing operations | $ | 221 |  |  | $ | 335 |  |  | $ | 517 |
Gain (loss) on disposition of discontinued operations – net of tax | — |  |  | — |  |  | 1 |
Net income (loss) | $ | 221 |  |  | $ | 335 |  |  | $ | 518 |
Basic shares: |  |  |  |  |
Weighted average shares outstanding | 65.8 |  |  | 67.0 |  |  | 67.5 |
Earnings (loss) per share – basic: |  |  |  |  |
Income (loss) from continuing operations | $ | 3.36 |  |  | $ | 5.00 |  |  | $ | 7.65 |
Gain (loss) on disposition of discontinued operations – net of tax | — |  |  | — |  |  | 0.02 |
Net income (loss) | $ | 3.36 |  |  | $ | 5.00 |  |  | $ | 7.67 |
Diluted shares: |  |  |  |  |
Weighted average shares outstanding – basic | 65.8 |  |  | 67.0 |  |  | 67.5 |
Effect of dilutive securities: |  |  |  |  |
Restricted stock | 0.5 |  |  | 0.6 |  |  | 0.8 |
Diluted weighted average shares outstanding | 66.3 |  |  | 67.6 |  |  | 68.3 |
Earnings (loss) per share – diluted: |  |  |  |  |
Income (loss) from continuing operations | $ | 3.33 |  |  | $ | 4.96 |  |  | $ | 7.56 |
Gain (loss) on disposition of discontinued operations – net of tax | — |  |  | — |  |  | 0.02 |
Net income (loss) | $ | 3.33 |  |  | $ | 4.96 |  |  | $ | 7.58 |
Non-vested restricted stock awards and restricted stock units (“Restricted Stock”) granted by the Company are treated as potential common shares outstanding in computing diluted earnings per share using the treasury stock method. Weighted average Restricted Stock of approximately 0.1 million were outstanding during the year ended December 31, 2025 and 2024, respectively, but were not included in the computation of diluted shares as the effect would be anti-dilutive or performance targets were not expected to be achieved for awards contingent upon performance. There were no weighted average Restricted Stock outstanding during the year ended December 31, 2023 that would have an anti-dilutive effect.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration